Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.

[1]  L. Ellis,et al.  Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines , 2005, Cancer.

[2]  David M Jablons,et al.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Lichinitser,et al.  Expression of Flt-1 and Flk-1 Receptors for Vascular Endothelial Growth Factor on Tumor Cells as a New Prognostic Criterion for Locally Advanced Breast Cancer , 2003, Bulletin of Experimental Biology and Medicine.

[4]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[5]  Edward S. Kim,et al.  Angiogenesis inhibitors in lung cancer , 2002, Current oncology reports.

[6]  R. Kerbel.  Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Hinton,et al.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. , 2001, Blood.

[8]  A. Casalini,et al.  Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma , 2001, The Journal of pathology.

[9]  R. Dziadziuszko,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)--a preliminary report. , 2001, Folia Histochemica et Cytobiologica.

[10]  A. Harris,et al.  Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. , 2000, Cancer research.

[11]  E. Brambilla,et al.  Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival , 1999, The Journal of pathology.

[12]  S. Abe,et al.  Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  C. Angeletti,et al.  Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. , 1997, British Journal of Cancer.

[14]  M. Volm,et al.  Prognostic value of vascular endothelial growth factor and its receptor Flt‐1 in squamous cell lung cancer , 1997, International journal of cancer.

[15]  L. Ellis,et al.  Angiogenesis and metastasis. , 1996, European journal of cancer.

[16]  A. Nicholson,et al.  Angiogenesis in primary lung cancer and lung secondaries. , 1996, European journal of cancer.

[17]  M. Toi,et al.  Clinical significance of the determination of angiogenic factors. , 1996, European journal of cancer.

[18]  A. Chella,et al.  Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (Stage IIIA‐N2): Impact of adjuvant therapies in a subset of patients at high risk of recurrence , 1996, Cancer.

[19]  C. Angeletti,et al.  Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  A. Harris,et al.  PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER , 1996, The Journal of pathology.

[21]  M. Volm,et al.  Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. , 1996, British Journal of Cancer.

[22]  D. Kerr,et al.  Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. , 1995, Biochemical and biophysical research communications.

[23]  K. Hiroshima,et al.  Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases , 1995, Cancer.

[24]  A. Bikfalvi.  Significance of angiogenesis in tumour progression and metastasis. , 1995, European journal of cancer.